[ Price : $8.95]
FDA approves GSKs Lynavoy (linerixibat), the first U.S.-authorized therapy specifically for cholestatic pruritus in patients with ...[ Price : $8.95]
Sarepta says it will submit to FDA by the end of April sNDAs to convert the accelerated approvals of its Amondys 45 and Vyondys 53...[ Price : $8.95]
FDA approves a higher-dose version of Novo Nordisks blockbuster weight-loss drug Wegovy (semaglutide) injection.[ Price : $8.95]
Ultrarare disease sufferers and advocates stage a mock funeral at FDA headquarters to grieve the lack of approved treatments for c...[ Price : $8.95]
CSL notes it is actively working with regulatory authorities to address the shortage and develop strategies to ensure a stable lon...[ Price : $8.95]
FDA approves a LivaNova PMA for its aura6000 System, a novel implantable device designed to treat adults with moderate to severe o...[ Price : $8.95]
FDA warns Eatontown, NJ-based Avertix Medical about Quality System, Medical Device Reporting, and Correction and Removal violation...[ Price : $8.95]
FDA warns Indias Patcos Cosmetics that it is marketing adulterated over-the-counter drug products that have significant violations...